Literature DB >> 14712175

State-specific prevalence of current cigarette smoking among adults--United States, 2002.

.   

Abstract

Cigarette smoking in the United States causes serious illnesses among an estimated 8.6 million persons and approximately 440,000 deaths annually, resulting in 157 billion dollars in health-related economic costs. To reduce smoking prevalence, morbidity, mortality, and economic impact, state tobacco-control programs should include interventions to help persons stop smoking. To assess the prevalence of current cigarette smoking among adults, attempts to quit, and receipt of physician advice to quit during the preceding year, CDC analyzed data from the 2002 Behavioral Risk Factor Surveillance System (BRFSS) survey. This report summarizes the results of that analysis, which indicated a threefold difference in smoking prevalence across the 50 states, the District of Columbia (DC), Guam, Puerto Rico, and the U.S. Virgin Islands (range: 9.5%-32.6%). To support smokers' attempts to quit, states/areas should implement comprehensive tobacco-control programs that include interventions to help persons stop smoking (e.g., quitlines).

Entities:  

Mesh:

Year:  2004        PMID: 14712175

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  17 in total

1.  Organizational systems to support publicly funded tobacco treatment services.

Authors:  Jane G Zapka; Mary Jo White; George Reed; Judith K Ockene; Elena List; Lori Pbert; Denise Jolicoeur; Sarah Reiff-Hekking
Journal:  Am J Prev Med       Date:  2005-05       Impact factor: 5.043

2.  Adult tobacco use levels after intensive tobacco control measures: New York City, 2002-2003.

Authors:  Thomas R Frieden; Farzad Mostashari; Bonnie D Kerker; Nancy Miller; Anjum Hajat; Martin Frankel
Journal:  Am J Public Health       Date:  2005-06       Impact factor: 9.308

3.  Smoking behavior in trucking industry workers.

Authors:  Nitin B Jain; Jaime E Hart; Thomas J Smith; Eric Garshick; Francine Laden
Journal:  Am J Ind Med       Date:  2006-12       Impact factor: 2.214

Review 4.  Smoking, traumatic event exposure, and post-traumatic stress: a critical review of the empirical literature.

Authors:  Matthew T Feldner; Kimberly A Babson; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2006-10-10

5.  Racial differences in eligibility and enrollment in a smoking cessation clinical trial.

Authors:  Andrea C King; Dingcai Cao; Catherine C Southard; Alicia Matthews
Journal:  Health Psychol       Date:  2011-01       Impact factor: 4.267

6.  Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration.

Authors:  Xiu Liu; Courtney Jernigan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-20       Impact factor: 5.067

7.  COPD is associated with a macrophage scavenger receptor-1 gene sequence variation.

Authors:  Jill A Ohar; Raymond F Hamilton; Siqun Zheng; Alireza Sadeghnejad; David A Sterling; Jianfeng Xu; Deborah A Meyers; Eugene R Bleecker; Andrij Holian
Journal:  Chest       Date:  2010-01-15       Impact factor: 9.410

Review 8.  Intimate partner violence victimization and cigarette smoking: a meta-analytic review.

Authors:  Cory A Crane; Samuel W Hawes; Andrea H Weinberger
Journal:  Trauma Violence Abuse       Date:  2013-07-22

9.  Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence.

Authors:  Xiangning Chen; Jingchun Chen; Vernell S Williamson; Seon-Sook An; John M Hettema; Steven H Aggen; Michael C Neale; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

10.  Onset and persistence of daily smoking: the interplay of socioeconomic status, gender, and psychiatric disorders.

Authors:  Eric O Johnson; Scott P Novak
Journal:  Drug Alcohol Depend       Date:  2009-05-31       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.